HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-10-17Clinical Trial Update: HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine [Phase 4]
Phase 4 trial evaluating darunavir/ritonavir plus etravirine in acutely HIV-infected patients was terminated; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-10-16Clinical Trial Update: Safety of and Immune Response to a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults [Phase 1]
Phase 1 clinical trial assessing safety and immune response of a Modified Vaccinia Ankara (MVA) HIV vaccine in HIV-uninfected adults; study …
-
FDA approval · 2017-10-13FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
The FDA approved AbbVie’s supplemental application for KALETRA (lopinavir/ritonavir), authorizing changes to the product labeling and/or add…
-
CLINICAL_TRIALS trial_result · 2017-10-13Clinical Trial Update: Adiposity and Airway Inflammation in HIV-Associated Airway Disease
A completed clinical trial exploring the link between adiposity and airway inflammation in HIV-associated airway disease.
-
CLINICAL_TRIALS trial_result · 2017-10-13Clinical Trial Update: Patient Portal to Support Treatment Adherence [NA]
A completed clinical trial evaluated a patient portal designed to support adherence to antiretroviral therapy.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-10-12Clinical Trial Update: Postprandial Endothelial Dysfunction After a High-Fat Meal in HIV-infected Men
A completed clinical trial evaluated postprandial endothelial function after a high-fat meal in HIV-infected men to assess cardiovascular ri…
-
CLINICAL_TRIALS trial_result · 2017-10-06Clinical Trial Update: Male Circumcision Against HIV Hukomboa [NA]
A completed clinical trial in Tanzania evaluated male circumcision as a strategy to prevent HIV infection.
-
FDA approval · 2017-10-06FDA Approved: NEVIRAPINE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved an Original Application for NEVIRAPINE (nevirapine) from Macleods Pharmaceuticals Limited, marking approval of a generic antire…
-
FDA approval · 2017-09-29FDA Approved: NORVIR — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for NORVIR (ritonavir) from AbbVie. The supplement updates the product labeling.
-
FDA approval · 2017-09-29FDA Approved: NORVIR — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for NORVIR (ritonavir) submitted by AbbVie.
-
FDA approval · 2017-09-28FDA Approved: DESCOVY — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for DESCOVY (emtricitabine and tenofovir alafenamide) from Gilead Sciences, updating the drug's labe…
-
CLINICAL_TRIALS trial_result · 2017-09-26Clinical Trial Update: School Support as Structural HIV Prevention for Adolescent Orphans in Kenya [Phase 2]
Phase 2 clinical trial update on school support as structural HIV prevention for adolescent orphans in Kenya completed.
-
FDA approval · 2017-09-25FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for EPIVIR (lamivudine) filed by ViiV Healthcare Company.
-
FDA approval · 2017-09-25FDA Approved: GENVOYA — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for GENVOYA (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) from Gilead Sci…
-
CLINICAL_TRIALS trial_result · 2017-09-20Clinical Trial Update: A Demonstration Project to Add Pre- or Post-exposure Prophylaxis to Combination HIV Prevention Services [Phase 4]
Phase 4 demonstration trial evaluating adding pre- or post-exposure prophylaxis to HIV prevention services completed with results posted in …
-
CLINICAL_TRIALS trial_result · 2017-09-18Clinical Trial Update: SSAT058: Atripla to Eviplera Switch in Patients Without Central Nervous System Symptoms [Phase 4]
Phase 4 trial update evaluating switching from Atripla to Eviplera in HIV patients without central nervous system symptoms.
-
CLINICAL_TRIALS trial_result · 2017-09-18Clinical Trial Update: Theory-based Text Messaging to Reduce Methamphetamine Use and HIV Risks Among MSM [NA]
A completed clinical trial investigating theory-based text messaging to reduce methamphetamine use and HIV risks among men who have sex with…
-
FDA approval · 2017-09-15FDA Approved: EDURANT — Supplemental Application (Janssen Products, LP)
The FDA approved a supplemental application for EDURANT (rilpivirine hydrochloride) submitted by Janssen Products, LP.
-
CLINICAL_TRIALS trial_result · 2017-09-15Clinical Trial Update: A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant Women [Phase 3]
This completed Phase 3, single-arm, open-label pharmacokinetic study evaluated multiple antiretroviral combinations (darunavir with ritonavi…
-
CLINICAL_TRIALS trial_result · 2017-09-14Clinical Trial Update: A Pharmacokinetic Evaluation of Etonogestrel (ENG) Implant and Antiretroviral Therapy [Phase 4]
Phase 4 pharmacokinetic study evaluating etonogestrel implant in the context of antiretroviral therapy.
-
CLINICAL_TRIALS trial_result · 2017-09-11Clinical Trial Update: Antiplatelet Therapy in HIV [Phase 2]
Phase 2 clinical trial update on antiplatelet therapy in HIV patients with cardiovascular considerations; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2017-08-31Clinical Trial Update: Effectiveness of Antiretroviral Therapy During Acute HIV Infection [Phase 1]
Phase 1 trial update assessing the effectiveness of antiretroviral therapy when started during acute HIV infection.
-
FDA approval · 2017-08-30FDA Approved: STRIBILD — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for STRIBILD (elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate) from G…
-
CLINICAL_TRIALS trial_result · 2017-08-30Clinical Trial Update: To Assess the Drug-drug Interaction Potential Between Dapivirine Vaginal Ring-004, Containing 25 mg of Dapivirine, and Clotrimazole 10 mg/g (1%) [Phase 1]
A Phase 1 study evaluated potential drug-drug interactions between the dapivirine vaginal ring (25 mg) and clotrimazole 1% topical cream; th…
-
CLINICAL_TRIALS trial_result · 2017-08-30Clinical Trial Update: HealthMap: an Interactive Health Plan Randomised Trial to Prevent Cardiovascular Disease in People With HIV [NA]
HealthMap is a randomized health-plan intervention trial to prevent cardiovascular disease in people with HIV. The study has completed.